🇺🇸 FDA
Patent

US 12005036

Methods of administering solriamfetol to lactating women

granted A61KA61K31/165

Quick answer

US patent 12005036 (Methods of administering solriamfetol to lactating women) held by AXSOME MALTA LTD. expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AXSOME MALTA LTD.
Grant date
Tue Jun 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/165